Showing results (41-50 of 46) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nature Medicine|May 27, 2020
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trialBruno Bockorny, Valerya Semenisty, Teresa Macarulla, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2026
Biomarker analysis from patients with metastatic PDAC treated with TGFβ antibody, NIS793, plus abraxane+gemcitabine vs. abraxane+gemcitabine alone in a phase II, open label, randomized studyMarc Pelletier, Jie Yang, Mukta Joshi, et al.Cancer Discovery|October 22, 2017
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional RepressionMaria Rusan, Kapsok Li, Yvonne Li, et al.Nature Medicine|June 13, 2024
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trialAndrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic AdenocarcinomaPascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade, et al.JCO Precision Oncology|September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic CancerRishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.Pageof 5